|
|
||||||||
Department of Physiology, College of Medicine, University of Arizona, Tucson, Arizona 85724-5051
| |
ABSTRACT |
|---|
|
|
|---|
Cross-linked hemoglobin (
-Hb) and
polyethylene glycol (PEG)-conjugated Hb have both been considered as
possible "blood substitutes." Previously, we showed that PEG-Hb
extravasates rapidly in the intestinal mucosa and causes transient
epithelial sloughing, resulting in temporary opening of the intestinal
epithelial barrier. In the present study, the rat mesenteric
preparation was used to quantify the effects of the two Hbs on
microvascular leakage to albumin and to investigate possible changes in
the integrity of the interendothelial cell junctions and the
endothelial actin cytoskeleton. In anesthetized Sprague-Dawley rats,
the microvasculature of a mesenteric window was perfused with
HEPES-buffered saline (HBS) containing 0.5 mg/ml BSA and 2 mg/ml

-Hb (n = 16) or PEG-Hb (n = 5) for 2 or 10 min. Controls
(n = 4) just received HBS-BSA. In some
experiments (n = 9 for 
-Hb ;
n = 5 for PEG-Hb), the perfusate was
then replaced by FITC-albumin in HBS-BSA for the next 3 min. The
vasculature was then perfusion fixed, stained for filamentous actin and
for mast cells, and viewed microscopically. In the remaining
experiments, the mesenteric microvasculature was stained with silver
nitrate to determine the number of endothelial junctional gaps per
length of venules. Both Hbs increased the number and area of leaks per
micrometer of venular length compared with control, but 
-Hb
increased to a greater extent than PEG-Hb. Formation of leaks was
accompanied by changes in the endothelial actin cytoskeleton and by an
increased number of endothelial gaps. Mast cell degranulation was
significantly greater (P < 0.05) in Hb-treated preparations compared with controls, but there was no direct
correlation between sites of degranulation and albumin leakage. These
Hbs appear to induce venular leakage in the mesentery by mechanisms
similar to those previously observed after treatment with histamine or
nitric oxide synthase inhibitors.
blood substitutes; actin cytoskeleton; silver nitrate; microscopy
| |
INTRODUCTION |
|---|
|
|
|---|
HEMOGLOBIN (Hb)-based oxygen carriers, such as
cross-linked Hb (
-Hb) and polyethylene glycol (PEG)-Hb, have been
proposed as blood substitutes for transfusions due to their plasma
expansion and oxygen transport capabilities. The development of such
substances is motivated by the dangers of blood incompatibility
reactions or infectious diseases in homologous blood transfusions. In
addition, Hb-based oxygen carriers have the advantage that they can be
sterilized and stored for prolonged periods of time. However, little is
known about the microvascular effects of blood replacement solutions and, in particular, their effects on microvascular permeability. It is
important to determine whether potential blood substitutes cause
microvascular leakage, because alterations in transvascular exchange of
plasma proteins disturb the fluid balance between blood and tissue. In
addition, increased microvascular leakage changes the kinetics of
delivery of intravascularly injected drugs, and of endogenous enzymes
and hormones, to various tissues. At times during which transfusions
are needed, for example, after hemorrhagic shock, it is important that
regulation of microvascular exchange is not compromised.
In previous publications (2, 5), using electron microscopy, we showed that PEG-Hb extravasates from intestinal mucosal capillaries via widened endothelial junctions and causes various ultrastructural changes in the intestinal mucosa and accompanying capillaries. Apart from epithelial detachment, these changes include mast cell degranulation, goblet cell secretion, and tissue edema. Mast cell degranulation can result in release of inflammatory mediators, such as histamine, leukotrienes, prostaglandin D2, and cytokines, which increase microvascular permeability, causing edema, and recruit and activate inflammatory cells, such as eosinophils and neutrophils (10).
In the present study, we investigated the effects of 
-Hb and
PEG-Hb on extravasation of BSA in the rat mesentery. The mesentery is
an excellent preparation for quantifying the degree of vascular leakage
invoked by particular mediators because the tissue is very thin and the
microvascular networks are almost two dimensional, thus facilitating
image acquisition and analysis. We have previously used the mesentery
to detect venular leaks to albumin after administration of histamine
(3, 29) or nitric oxide synthase (NOS) inhibitors (4). In those
experiments, we showed that the formation of leaks is accompanied by
changes in the endothelial actin cytoskeleton and by increases in the
number of endothelial junctional gaps per surface area of venule. In
the present study, we compare our results with 
-Hb and PEG-Hb
with those obtained using other mediators.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|

-Hb.
The 
-Hb was obtained from the United States Army (kind gift of
Dr. Alan Rudolph, Naval Research Center, Washington, DC). It is
stabilized by intramolecularly cross-linking the
-subunits within
the Hb tetramer and contains 4.74% methemoglobin and 0.125 EU/ml
endotoxin. This product has a half-life of 3-24 h in the circulation, depending on the species and dose (10-12).
PEG-conjugated Hb. The PEG-Hb was formulated in 5 mmol/l NaHCO3, 4 mmol/l Na2HPO4, and 150 mmol/l NaCl (methemoglobin <5%, endotoxin <0.5 EU/ml) at a concentration of 60 mg/ml. This product has a longer half-life in the circulation of dogs (58.3 h; see Ref. 8), when the solution is exchange transfused 30%, than does Hb (4.0 h; see Ref. 22). Other details regarding the PEG-Hb have been described elsewhere (22).
Both Hbs were stored in 1-ml aliquots at
20°C in
microcentrifuge tubes. Immediately before use, an aliquot was thawed at 4-8°C, diluted to 2 mg/ml with HEPES-buffered saline (HBS),
and warmed to 37°C by placing the container in a water bath, and
the pH was measured to ensure that it had not drifted from 7.4.
Cannulation and perfusion of rat mesentery. The animal procedure was similar to that described previously (3) and is summarized here. Twenty-seven male Sprague-Dawley rats (350-400 g) were anesthetized with an intramuscular injection of pentobarbitone sodium (6 mg/100 g). The abdomen was opened, and several contiguous well-vascularized mesenteric windows were selected and spread out flat over a Plexiglas platform. The superior mesenteric artery was cannulated near the selected mesenteric windows, and the appropriate arterioles and venules bordering the windows were ligated to allow perfusion only of the chosen windows.
The mesenteric windows were flushed clear of blood with HBS (pH 7.4)
containing 0.5% BSA and 1 U/ml heparin at 37°C and were perfused,
at an inlet pressure of 100 mmHg, with this solution alone (controls, 4 animals), HBS-BSA plus 2 mg/ml 
-Hb (3 animals for 2 min; 12 animals for 10 min), or HBS-BSA plus 2 mg/ml PEG-Hb for 10 min (5 animals). In nine of the 
-Hb and in all the PEG-Hb experiments,
the perfusate was then replaced by FITC-albumin (Sigma, St. Louis, MO)
in HBS-BSA for the next 3 min. As soon as the vasculature of the
windows was filled with FITC-albumin, as judged by the color, the
pressure was adjusted to 40 mmHg, and the portal vein, which acted as
the flow outlet, was clamped. After 3 min, the clamp was removed, and 3 ml of fixative (3% formaldehyde in HBS) were perfused via the cannula
at a pressure of 100 mmHg. Next, the pressure was reduced to 40 mmHg,
the portal vein was clamped, and fixation was continued for 30 min. The
vasculature of the mesenteric windows was then perfused, via the
cannula, with a cocktail of 3% formaldehyde, 0.1% Triton X-100, and
rhodamine phalloidin (10 U/ml; Molecular Probes, Eugene, OR) in HBS for 30 min at 4°C to promote staining of endothelial actin fibers. After staining, the vasculature was perfusion fixed for 30 min with 3%
formaldehyde and then flushed with HBS. The mesenteric tissue was
carefully excised, and two windows from each preparation were mounted
between two thin glass coverslips using aqueous mounting medium
(Vectashield; Vector Laboratories, Burlingame, CA). The remaining
mesenteric windows from each experiment were spread flat on microscope
slides and suffused with 1% toluidine blue for 15 min before mounting.
Toluidine blue was used to stain the mast cells to determine the
numbers that had degranulated. The PEG-Hb preparations were not
included in the mast cell study due to shortage of material.
Degranulated mesenteric mast cells, identified by the presence of
intracellular granules released into the surrounding tissue, were
counted within each circular ×20 field of view of a Zeiss light
microscope (field area 1.13 mm2). Rows of fields were
counted systematically from left to right. Cells located in the
periphery of the field were only counted if at least one-half of the
cell area was within the field. The error of repeat counting was
<2%. About 30 fields were counted for each mesenteric window.
Assessment of venular leakage. An
assessment of overall vascular leakage was made by measuring the number
and area of regions with extravascular FITC-albumin. Slides were
examined using a Zeiss Axioplan microscope with a ×10 objective
and numerical aperture (NA) 0.6, fitted for epifluorescence. The light
source was a 100-W mercury lamp for epifluorescence and a halogen lamp
for transmitted illumination. A video camera (Optronix VI 470) was
mounted at the camera port of the microscope. Five images of leaky
vessel networks from each mesentery, produced by epifluorescence with the appropriate FITC excitation and emission filters (
= 488 and 515 nm, respectively), were viewed on a black and white monitor and also recorded on a video recorder. Each slide was only exposed to
the excitation wavelength for 5 s. Recordings were also made of the
networks under transillumination. Videotaped images were later analyzed
using an analog-to-digital converter and appropriate software (NIH
Image) to measure the length and diameter of each venule, the number of
leaks per venule, and the area of each leak. If a leak was positioned
at a vascular junction, the leak area was divided by the number of
venules involved. Data were pooled within each group (i.e., 
-Hb
for 10 min), and the following values were calculated:
1) average number of leaks per
length of venule, 2) average leak
area per micrometer of venule, and 3) size distribution of leaks.
Actin cytoskeleton. Epifluorescence microscopy was used to examine the structure and degree of integrity of the endothelial actin cytoskeleton of mesenteric venules from all groups. Photographs of venules were taken, in pairs, using the FITC filter and rhodamine filter in turn, through a ×63 NA 1.25 oil immersion objective. The photographs were taken to record representative examples of leaky and nonleaky venules, and the only criterion used for selecting a vessel for photography was its clarity under epifluorescence microscopy.
Silver staining. The preparations that
were not perfused with FITC-albumin were stained with silver nitrate to
delineate the endothelial cell junctions and demonstrate the presence
of junctional gaps (7 controls and 6 
-Hb for 10 min). The
procedure used was a modified version of that developed by McDonald
(16). Briefly, the preparation was perfusion fixed with sodium
cacodylate-buffered 1% paraformaldehyde and 0.5% gluteraldehyde for 5 min, using a handheld syringe. To obtain the desired results, it was
essential to flush a relatively large volume of fixative (25 ml)
through the system. Next, 0.9% NaCl was flushed through for 2 min,
followed by 5% glucose for 10 s, 0.2% silver nitrate for 15 s, and
glucose for 10 s. Finally, fixative was flushed through for 1 min. The tissue was quickly excised, spread out in cacodylate buffer, and exposed to bright light for 8-15 min. When the vascular tree
became visible through a dissecting microscope, the tissue was removed from the light, dehydrated, cleared in toluene, and mounted for microscopic observation. Junctional gaps were easily discernible in
mesenteric venules as focal deposits of silver along the cell borders.
Between 5 and 15 venules were chosen from each preparation in which to
count the number of gaps. Venules were chosen according to whether they
had stained with sufficient intensity. In each case, the venule length
was measured, using a microscopic eyepiece calibrated scale, so that
the number of gaps per length of venule could be calculated. Finally,
the diameters of 40-130 venular silver deposits for each treatment
group were measured using photomicrographs. All deposits appearing in
the images were included in the counts.
Statistical analysis. For parameters, such as mast cell degranulation and numbers of junctional gaps, the slides were coded and later analyzed. Each parameter was compared between different groups using one-way ANOVA. If a significant difference was found between groups, pairs of groups were compared using the Student's t-test with a P value <0.05 to determine statistical significance. All values are presented as means ± SE. The n used in these studies was the number of venules per group.
| |
RESULTS |
|---|
|
|
|---|
The results from this study have been compared with those from three of our previous studies, one using histamine as a mediator (3), one using NG-monomethyl-L-arginine (L-NMMA; see Ref. 4), and the third using histamine or L-NMMA followed by silver staining to identify junctional gaps (1). Control values from the histamine study for FITC-BSA venular leakage have also been used in the comparison.
Distribution of leaks. Microscopic
examination of control mesenteric preparations by epifluorescence
revealed very few leaky sites after perfusion with HBS-BSA (6 experiments), but preparations treated with 
-Hb or PEG-Hb showed
many leaky sites. The leakage occurred in venules but not in arterioles
or capillaries. The total number of venules examined for 
-Hb (2 min), 
-Hb (10 min), and PEG-Hb (10 min) were 41, 128, and 299, respectively. The percentage of venules demonstrating leaks for

-Hb (2 min), 
-Hb (10 min), and PEG-Hb (10 min) were 39, 84, and 41%, respectively. Corresponding values for L-NMMA (3 min) and histamine (3 min) were 71 and 46%. After 2 min of 
-Hb
treatment, most leaks were <500
µm2 in area. This compares with
a luminal surface area of endothelial cells that ranges from 400 to 900 µm2 (3). Perfusion with

-Hb or PEG-Hb for 10 min resulted in the appearance of some
larger leaks. In many cases, a few of the leaks were >5,000
µm2 in area.
Quantification of leaks. The number of
leaks per venule length, as a function of type and duration of
treatment, is shown in Fig.
1A.
Values for 2-min 
-Hb and 10-min PEG-Hb were very similar to each
other, significantly greater than for controls, and significantly
smaller than for histamine, 10-min 
-Hb, and 3-min
L-NMMA. With regard to average leak area per venule length (Fig. 1B), all mediators gave values
that were significantly greater than for control. The value for 10- min

-Hb was significantly greater than for all other cases. Thus

-Hb causes leaks that increase in number and in area with time
from 2 to 10 min. PEG-Hb for 10 min produced leak numbers per venule
length and leak area per venule length similar to those of 2-min

-Hb, but the size distribution of leaks was wider.
There were fewer very small leaks and several large leaks in PEG-Hb
specimens.
|
It has been suggested that FITC-BSA can increase the microvascular
leakage produced by NOS inhibitors (27). To determine whether this
effect significantly affected the results, two experiments were
performed in which mesenteric windows were perfused for 10 min with

-Hb, followed by tetramethyl rhodamine isothiocyanate-labeled BSA
for 3 min. In these experiments, although the area of leaks per venule
length was markedly reduced compared with FITC-BSA, the numbers of
leaks were very similar (41.9 and 43.5 × 10
4 vs. a mean value of
53.0 × 10
4 for
FITC-BSA). Therefore, it is unlikely that stimulation of the FITC-BSA
was responsible for the formation of leaks after perfusion of

-Hb.
Appearance of venular leaks and accompanying changes
in endothelial actin cytoskeleton. In control
preparations, as noted previously (4), there were very few venular
leaks to FITC-BSA, and the endothelial cell actin cytoskeleton
consisted of peripheral fibers at the cell-cell junctions. After 10 min
of treatment with 
-Hb, many leaks could be seen (Figs.
2A and
3A),
some small and others more extensive. In Fig.
2A, FITC-BSA appears to be leaving the
venule in the form of streams. This phenomenon occurred occasionally
and was also observed in preparations treated with L-NMMA
(4). The endothelial actin cytoskeletons of vessels depicted in Figs.
2A and
3A are demonstrated in Figs.
2B and
3B (taken using filters for
FITC-albumin and rhodamine-phalloidin, respectively). Comparison of
Fig. 2, A and
B, reveals that a cluster of small
leaks are coincident with the endothelial cell junction, as outlined by
rhodamine phalloidin staining of the peripheral actin rim (PAR). The
precise positions of these small leaks coincide with distinct gaps in
the PAR. We have observed this phenomenon previously in preparations
treated with histamine (3, 29) or with L-NMMA (4). This
type of disruption was rarely seen in control preparations. In
controls, the PARs formed fairly continuous boundaries around each
endothelial cell (3, 4).
|
|
In regions of venules in which the leaks were more extensive (i.e., Fig. 3A), the PARs were very disrupted, and, in addition, distinct actin fibers, largely aligned with the longitudinal axis of the vessel, were evident in the central region of the cell. As shown in Fig. 3B, the central actin fibers were often absent within the cell most closely associated with the large leak but were present within surrounding cells. This observation is consistent with our hypothesis (3) that the central fibers provide extra support for the cells so that they may retain their original shape in the face of the action of various mediators.
Mast cell degranulation. In the
preparations that were perfused with 
-Hb for 2 or 10 min,
toluidine blue staining revealed the presence of degranulated mast
cells (Fig. 4). Figure
5 shows the number of degranulated mast
cells per microscopic field of view for 
-Hb preparations,
compared with previously published results for histamine and
L-NMMA (1). The 
-Hb-treated preparations show
significantly more mast cell degranulation than those undergoing the
other treatments. However, the 
-Hb-treated and control
preparations, unlike the other groups shown in Fig. 5, were not
pretreated with the mast cell stabilizer chromolyn. If the other groups
(histamine and L-NMMA) had not been pretreated with
chromolyn, the degree of mast cell degranulation observed in those
cases would have been higher. The reason for not using a mast cell
stabilizer was that 
-Hb has been used extensively in clinical
trials without stabilizers, and we wished to determine the effects of
the Hb in the form in which it is currently being administered.
|
|
Because mast cells, on degranulation, release substances such as
histamine and prostaglandins that cause venular leakage (7), we
determined whether there was any correlation between extent of venular
leakage and degree of mast cell degranulation for each preparation
treated with 
-Hb. The mean number of degranulated mast cells was
plotted against the mean number of leaks per venule length, or the mean
leak area per venule length, for each experiment (plots not shown).
There was no correlation between degree of mast cell degranulation and
mean number of leaks per venule length (r2 = 0.01) or
between mast cell degranulation and mean leak area per venule length
(r2 = 0.02).
Silver-stained endothelial junctional
gaps. The appearance of mesenteric microvessels from
10-min 
-Hb-treated preparations, after staining with silver
nitrate, is shown in Fig. 6. Figure 6A shows an arteriole in which the
endothelial cell boundaries are very clearly visible as continuous
silver lines, with no silver deposits (gaps). Gaps were never seen in
arterioles. Note the characteristic long, thin, spindly shape of the
arteriolar endothelial cells. Figure 6,
B and
C, shows silver-stained small venules. The staining is lighter, and silver deposits (gaps) along the cell
borders are clearly visible. The endothelial cells are less spindly
than those observed in arterioles. Larger venules showed similar silver
deposits, but due to the difficulty of locating reasonable lengths of
large venules in a single plane of focus, photographs are not
presented. Figure 6C demonstrates a
cluster of silver deposits that we noticed in vessels treated with

-Hb. One endothelial cell is partially separated from its
neighbors by seven gaps. The mean number of gaps per venule length is
shown in Fig. 7 for control and 10-min

-Hb-treated preparations. Previously published results for 3-min
histamine and 3-min L-NMMA (1) are also included for
comparison. The results for 
-Hb and L-NMMA are
similar to each other and significantly greater than for histamine, which is significantly greater than for controls. However, control preparations were not devoid of gaps. All controls showed some gaps
scattered throughout the venular endothelium.
|
|
Unfortunately, we were not able to show fluorescent leaks and
silver-stained gaps together in the same preparation. The processes involved in the silver staining removed all traces of fluorescence. Therefore, we were unable to show a direct correlation between leak
sites and gap positions. However, a plot of mean leak area per venule
length versus mean number of gaps per venule length obtained from
different treatments demonstrated a very high correlation (r2 = 0.99 for a
second-degree polynomial fit; Fig.
8A).
Each data point represents the mean value for a given treatment (i.e.,

-Hb, histamine, etc.). This finding is consistent with a previous
observation (30) that the number of venular gaps, as determined by
electron microscopy, was correlated with the amount of extravasation of
-lactalbumin from rat mesenteric venules exposed to histamine. A
plot of the mean number of leaks per venule length versus mean number
of gaps per venule length did not show a strong correlation (Fig.
8B). Preparations treated with
L-NMMA for 3 min showed a greater number of leaks per
venule length, but fewer gaps per venule length, than did preparations
treated with 
-Hb for 10 min.
|
The mean diameters of venular silver deposits (means ± SE) from mesenteries treated with HBS-BSA, L-NMMA,
histamine, and 
-Hb (10 min; 4 rats in each case) were 0.94 ± 0.06 µm (n = 41), 1.30 ± 0.04 µm (n = 50), 1.42 ± 0.04 µm
(n = 51), and 1.78 ± 0.04 µm (n = 131), respectively. All
three mediators gave silver deposit diameters that were significantly
larger than control values, and the 
-Hb mean value was
significantly larger than values for L-NMMA and histamine.
| |
DISCUSSION |
|---|
|
|
|---|
This study has demonstrated that 
-Hb and PEG-Hb, both of which
have been considered as possible blood substitutes, cause venular
leakage in the rat mesentery, similar to that produced by histamine and
NOS inhibitors, such as L-NMMA. This finding is contrary to
the results reported by the only other group that has used
epifluorescence to determine the effects of Hb-based oxygen carriers on
the permeability of microvascular networks (23). Those authors
concluded that 
-Hb does not enhance permeability for FITC-dextran
(mol wt 150,000) in the microcirculation of striated skin muscle in
conscious hamsters. There are several ways to explain this apparent
discrepancy. First, the 
-Hb came from different sources; the

-Hb used by the other authors came from Baxter Healthcare,
whereas that used in these experiments came from the United States
Army. Even so, it is unlikely that this difference is the reason for
the discrepancy, because the two products contain the same chemical
modifications. However, as stated by D'Agnillo and Alayash (9), a
strict comparison between the two products has not been made in the
literature. Second, the tracer used by Nolte et al. (23) was
considerably larger than BSA, which has a molecular weight of 69,000 and a Stokes-Einstein radius of 37 Å, and many studies have shown that
larger molecules do not extravasate from microvessels as easily as
smaller molecules (i.e., Ref. 26). Third, the fluorescent tracer was
injected into the circulating blood and thus was present within the
vasculature when the observations were made. This means that the leaks
could only be detected in cases in which the FITC-dextran had diffused
away from the vessels into the tissue. In the mesentery, as shown in
Fig. 2C, small leaks may be confined
to the vessel wall and difficult to visualize if the microvasculature
has not been flushed free of tracer before the observations are made.
Occasionally, some vessels show streams of FITC-BSA entering the tissue
(Fig. 2A). A reason for the lack of
extensive diffusion from some microvascular beds was suggested by Majno
and Palade in 1961 (15). They observed, using electron microscopy, that
particles of mercuric sulfide (HgS), ranging in diameter
from 70 to 350 Å, leaked through venular endothelium of striated
muscle after histamine treatment but were then retained by the
underlying basement membrane. Thus the tracers were restricted to a
compartment close to the venule. They concluded, "The average diameter of the blood proteins is close to 40 Å, and if the basement membrane is capable of retaining almost all the particles of HgS down
to a diameter of 70 Å, it is clear that the filtration of protein
molecules should encounter some difficulty." McDonald (16) made a
similar observation. He reported that once the tracer, monastral blue,
had leaked through junctional gaps, it tended to cross the endothelial
basal lamina but not the basal lamina of the underlying pericytes. If
the 150,000 molecular weight dextran was being impeded in a similar way
in its passage from microvessels of striated muscle, it is unlikely
that Nolte et al. (23) could have detected such local, constrained
leaks. They assessed leakage by densitometric quantification of the
mean fluorescence intensity in the perivascular tissue. Thus they did
not measure individual leaks. No information is given regarding the
exact location of the perivascular tissue regions with respect to the
vessels. If the regions were too close to the vessels, the leaks would
have been masked by the intravascular tracer, and if the regions were too distant, the leaks would have been missed. Fourth, it is possible that the microvasculature of the hamster striated skin muscle is just
less permeable than that of the rat mesentery.
In this study, we have presented evidence that suggests that FITC-BSA leaks through localized endothelial junctional gaps similar to those produced by histamine and inhibition of NOS (6, 13). Because local disruption of the endothelial actin cytoskeleton occurs at leak sites, it is probable that alterations in the arrangement of the cytoskeleton play a role in the formation of the junctional gaps. The findings of this study will now be discussed in detail.
Venular leakage. Common to the
response of the mesenteric microvasculature to L-NMMA (4),
there was a slight widening of the leak size distribution after 10 min
of 
-Hb treatment time compared with 2 min. Increased treatment
time from 2 to 10 min increased the number of leaks per venule length
2.4-fold and the leak area per venule length 4.8-fold. These results
suggest that, during treatment with 
-Hb, the mean size of
individual leaks increases.
The fact that perfusion with PEG-Hb for 10 min produced significantly
less leakage than perfusion with 
-Hb for the same time period is
noteworthy. One possible explanation for the difference could be that,
since PEG-Hb is a larger molecule than 
-Hb (Stokes-Einstein radius of 250 Å vs. 56 Å), it does not accumulate so easily in the
interendothelial cell clefts. Thus the amount of iron released from the
Hb derivative per unit volume of fluid in the cleft may be smaller.
Free iron is known to catalyze production of the hydroxyl radical that
causes tissue damage. Any direct effects that the PEG-Hb might have on
junctional integrity would thus tend to be reduced relative to those of

-Hb. Alternatively, PEG-Hb may be more stable and may not release
its iron so easily. However, this latter option is unlikely,
considering the rate at which it extravasates from intestinal mucosal
capillaries (2).
Changes in endothelial actin
cytoskeleton. Changes in the endothelial actin
cytoskeleton produced by 
-Hb were only present at leaky sites and
were very similar to those previously noted after treatment with
L-NMMA (4). These include focal breaks in the PAR,
extensive disruption of the actin cytoskeleton accompanying larger
leaks, and the appearance of actin fibers in the central region of the
cell that were oriented, to some degree, with the longitudinal axis of
the vessel. It is possible that the focal breaks in the PARs could have
led to the formation of the endothelial gaps, identified by the
presence of silver deposits. Assuming that the PAR acts as a scaffold
to maintain endothelial cell shape, a break in the PAR would tend to
reduce cell membrane tension in that region, causing the cell to
passively retract from its neighboring cell in that specific region,
thus forming a gap. The fact that the focal breaks in the PAR caused by
Hb were similar in size (~1.8 µm) to the silver deposits marking
the gaps supports this hypothesis.
Mast cell degranulation. We previously
reported that perfusion of mesenteric networks with L-NMMA
caused some mast cell degranulation, even in the presence of chromolyn
(4). We hypothesized that, since mast cells can be degranulated by
superoxide and nitric oxide (NO) acts as a scavenger for superoxide,
the L-NMMA was causing mast cell degranulation by depleting
the tissue of NO. Because 
-Hb also scavenges NO, it could be
causing mast cell degranulation by a similar mechanism. We previously
suggested (4) that, because of mast cell potency and strategic
location, we could not rule out mast cell secretory products as
contributors to at least part of the leak production and endothelial
cell cytoskeletal rearrangement caused by L-NMMA. In fact,
in the case of 
-Hb, when comparing 2- and 10-min values, the mean
number of degranulated mast cells and the mean number of leaks per
venule length increase by factors of 1.9 and 2.4, respectively. Thus,
at first sight, it appears that mast cell degranulation plays a major
role in 
-Hb-induced leak formation. However, when the analysis is
separated into individual experiments and correlation coefficients are
calculated, the correlation no longer holds. Therefore, it appears
that, although mast cell degranulation definitely accompanies leak
formation, it does not directly produce the leaks.
Silver-stained endothelial junctional
gaps. The average number of gaps per venule length in
control preparations [100 ± 40 (SE)/µm × 10
4] was considerably
greater than the average number of leaks per venule length [3.6 ± 0.2 (SE)/µm × 10
4]. Therefore,
either a large proportion of the apparent gaps are not open and/or
several gaps contribute to a single leak. The existence of gaps that do
not allow leakage of large tracers has been reported previously. For
example, McDonald (16) observed that, 10 min after application of
substance P, venules in the rat trachea showed silver deposits but no
leakage to monastral blue. At shorter time points after application of
substance P, leaks were observed. The disparity between the number of
gaps versus number of leaks is also seen after treatment with

-Hb, histamine, or L-NMMA, but its magnitude is reduced.
Our study demonstrated that the leak area, rather than the leak number,
per venule length was closely correlated with the number of gaps per
venule length. This finding is consistent with the possibility that
several gaps can result in one large leak, rather than in a few small,
discrete leaks. However, the correlation between leak area and number
of gaps was not linear when effects of different mediators were
compared (i.e., 
-Hb caused an average leak area per venule length
5.3 times larger than that produced by histamine, but the number of
gaps produced was only 1.6 times higher). Because the FITC-BSA was
contained in the microvasculature at the same pressure in all cases,
this finding suggests that the gaps caused by a given mediator are not
identical to those produced by another mediator. In fact, we showed
that the average size of the silver deposits observed after treatment
with 
-Hb was significantly larger than that of deposits observed
after histamine or L-NMMA. This size difference could
account, at least partially, for the increased leak area observed after
perfusion with 
-Hb. Differences in the average sizes of different
populations of silver deposits have been reported previously. Hirata et
al. (13) reported that, in the rat tracheal mucosa after treatment with
substance P, deposits in postcapillary venules were larger than those
in collecting venules. Our control value for mean diameter of silver
deposits closely approximates the value obtained by Baluk et al. (6),
1.16 ± 0.02 µm, in postcapillary venules of the rat trachea 10 min after application of substance P, at which time venular leaks had
vanished. Our histamine value is very similar to the value obtained by
the same authors 1 min after application of substance P when venular
leaks were apparent. Apart from the larger diameter of silver deposits
produced by 
-Hb, the clustering of gaps that we observed in

-Hb-treated preparations could account for the larger leaks
compared with histamine, because several neighboring gaps could
contribute to the same leak.
Possible mechanisms for leak formation by
Hbs. One property of Hb that lends itself to the
disruption of endothelial junctions is its strong affinity for NO. As
we have stated previously (4), inhibition of NO results in a reduction
of intracellular cGMP (20), which, in cultured endothelial cells, leads
to contraction of actomyosin filaments and possible cell contraction to
produce a widening of the intercellular clefts (24). Our previous
experiments, in which we demonstrated that perfusion of the mesenteric
microcirculation with NOS inhibitors nitro-L-arginine
methyl ester and L-NMMA also caused venular leakage (4),
support this hypothesis. Second, levels of superoxide anions, produced
by mitochondrial function, may increase if there is less NO available
to scavenge the superoxide (14). Excess quantities of superoxide anions
may lead to tissue damage. In addition, 
-Hb and PEG-Hb may
produce reactive oxygen species (ROS) independent of their ability to
deplete the tissue of NO. For example, oxyhemoglobin can convert to
methemoglobin and release superoxide as a by-product. Also, levels of
superoxide anions in the tissue increase when blood is diluted with
solutions such as HBS-BSA, because, unlike plasma, these solutions do
not contain ROS scavengers, such as catalase and superoxide dismutase (19). The excess ROS then react with Hb and cause it to release some
free iron from the heme group (25). The free iron catalyzes production
of the hydroxyl radical (OH ·) by the Fenton reaction (18).
The hydroxyl radical is a far more potent mediator of tissue damage
than is superoxide, and it propagates lipid peroxidation (21). Thus the
effects of various Hb-based blood substitutes on venular leakage may
depend on the affinity of the product for NO and/or on the propensity
of the product to release free iron.
The effects of 
-Hb and PEG-Hb on venular leak formation have
important implications regarding their use as blood substitutes. In a
previous study (2), we showed that PEG-Hb rapidly extravasates from the
intestinal mucosal microcirculation. Therefore, the effect on
microvascular leakage is not limited to the mesentery. If 
-Hb and
PEG-Hb increase transport of plasma proteins from the blood stream into
the tissue, this means that transport of nutrients and drugs between
blood and tissue will also be compromised. Thus it is important to
develop Hb-based blood substitutes that do not cause excess
microvascular leakage.
| |
ACKNOWLEDGEMENTS |
|---|
I thank Dr. Gavin Thurston for ideas that contributed to this research, particularly those regarding the silver stain technique and the visualization of endothelial actin, and for constructive criticism of the manuscript. In addition, I thank Lisa Wilson for expertise in animal surgery and Dirk Hamlin for assistance in collection and analysis of data.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant HL-53047-04.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: A. L. Baldwin, Department of Physiology, College of Medicine, University of Arizona, Tucson, AZ 85724-5051 (E-mail: abaldwin{at}u.arizona.edu).
Received 8 October 1998; accepted in final form 28 March 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Al-Naemi, H.,
G. Thurston,
and
A. L. Baldwin.
Changes in venular permeability due to L-NMMA and histamine treatments (Abstract).
Microcirculation
4:
150,
1997.
2.
Baldwin, A. L.
Blood substitutes and the intestinal microcirculation: extravasation and ultrastructural alterations.
In: Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges, edited by R. M. Winslow,
K. D. Vandergriff,
and M. Intaglietta. Boston, MA: Birkhauser, 1997, p. 19-37.
3.
Baldwin, A. L.,
and
G. Thurston.
Changes in endothelial actin cytoskeleton in venules with time after histamine treatment.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H1528-H1537,
1995
4.
Baldwin, A. L.,
G. Thurston,
and
H. Al Naemi.
Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton.
Am. J. Physiol.
274 (Heart Circ. Physiol. 43):
H1776-H1784,
1998
5.
Baldwin, A. L.,
L. M. Wilson,
and
J. E. Valeski.
Ultrastructural effects of intravascularly injected polyethylene glycol-hemoglobin in intestinal mucosa.
Am. J. Physiol.
275 (Heart Circ. Physiol. 44):
H615-H625,
1998
6.
Baluk, P.,
A. Hirata,
G. Thurston,
T. Fujiwara,
C. R. Neal,
C. C. Michel,
and
D. M. McDonald.
Endothelial gaps: time course of formation and closure in inflamed venules of rats.
Am. J. Physiol.
272 (Lung Cell. Mol. Physiol. 16):
L155-L170,
1997
7.
Bergendorff, A.,
and
B. Uvnas.
Storage properties of rat mast cell granules in vitro.
Acta Physiol. Scand.
87:
213-222,
1973[Medline].
8.
Concover, C. D.,
P. Malatesta,
L. Lejeune,
C.-L. Chang,
and
R. G. L. Shorr.
The effects of hemodilution with polyethylene glycol bovine hemoglobin (PEG-Hb) in a conscious porcine model.
J. Investig. Med.
44:
238-246,
1996[Medline].
9.
D'Agnillo, F., and A. Alayash. Site specific modifications
and toxicity of blood substitutes: the case of diaspirin cross-linked
hemoglobin. Adv. Drug Deliv. Rev. In
press.
10.
Estep, T. N.,
E. W. Bobka,
A. A. Ebeling,
T. T. Hai,
D. J. Nelson,
R. J. Pankau,
and
A. Srnak.
Novel aspects of diaspirin cross-linked hemoglobin synthesis and purification. (Abstract).
Biomater. Artif. Cells Artif. Organs
17:
636,
1989.
11.
Estep, T.,
J. Gonder,
I. Bornstein,
S. Young,
and
R. Johnson.
Biological evaluation of diaspirin crosslinked hemoglobin solutions. (Abstract).
Biomater. Artif. Cells Immobilization Biotechnol.
19:
378,
1991.
12.
Hess, J. R.,
S. O. Fadore,
L. S. L. Tolentino,
and
N. R. Bangal.
The intravascular persistence of DBBF-hemoglobin.
In: Progress in Clinical and Biological Research. Red Cell: 7th Ann Arbor Conference, edited by G. Brewer. New York: Liss, 1989, vol. 319, p. 351-360.
13.
Hirata, A.,
P. Baluk,
T. Fujiwara,
and
D. M. McDonald.
Location of silver staining at endothelial gaps in inflamed venules examined by scanning electron microscopy.
Am. J. Physiol.
269 (Lung Cell. Mol. Physiol. 13):
L403-L418,
1995
14.
Kubes, P.,
S. Kanwar,
X.-F. Niu,
and
J. P. Gaboury.
Nitric oxide synthesis inhibition induces leukotriene adhesion via superoxide and mast cells.
FASEB J.
7:
1293-1299,
1993[Abstract].
15.
Majno, G.,
and
G. Palade.
Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron microscopic study.
J. Biophys. Biochem. Cytol.
11:
571-605,
1961.
16.
McDonald, D. M.
Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli.
Am. J. Physiol.
266 (Lung Cell. Mol. Physiol. 10):
L61-L83,
1994
17.
Metcalfe, D. D.
Mast cell mediators with emphasis on intestinal mast cells.
Ann. Allergy Asthma Immunol.
53:
563-575,
1984.
18.
Misra, H. P.,
and
I. Fridovich.
The generation of superoxide radical during the autoxidation of hemoglobin.
J. Biol. Chem.
247:
6960-6962,
1972
19.
Moison, R. M. W.,
E. J. H. A. van Hoof,
P. C. Clahsen,
D. van Zoeren Grobben,
and
H. M. Berger.
Influence of plasma preparations and donor red blood cells on the antioxidant capacity of blood from newborn babies: an in vitro study.
Acta Paediatr.
85:
220-224,
1996[Medline].
20.
Moncada, S.
The L-arginine oxide pathway.
Acta Physiol. Scand.
145:
201-227,
1992[Medline].
21.
Motterlini, R.,
R. Foresti,
K. Vandergriff,
M. Intaglietta,
and
R. M. Winslow.
Oxidative-stress response in endothelial cells exposed to acellular hemoglobin solutions.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H648-H655,
1995
22.
Nho, K.,
D. Glower,
S. Bredehoeft,
S. Shankar,
and
R. Shorr.
A PEG-bovine hemoglobin: safety in a canine dehydrated hypovolemic-hemorrhage shock model.
Biomater. Artif. Cells Immobilization Biotechnol.
20:
511-524,
1992[Medline].
23.
Nolte, D.,
A. Botzlar,
S. Pickelmann,
E. Bouskela,
and
K. Messmer.
Effects of diaspirin-cross-linked hemoglobin (DCLHb) on the microcirculation of striated skin muscle in the hamster: a study on safety and toxicity.
J. Lab. Clin. Med.
130:
314-327,
1997[Medline].
24.
Oliver, J. A.
Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability.
J. Cell. Physiol.
151:
506-511,
1992[Medline].
25.
Paller, M. S.
Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity.
Am. J. Physiol.
255 (Renal Fluid Electrolyte Physiol. 24):
F539-F544,
1988
26.
Reimann, I.,
C. C. Arnoldi,
and
O. S. Nielsen.
Permeability of synovial membrane to plasma proteins in human coxarthrosis: relation to molecular size and histologic changes.
Clin. Orthop.
147:
296-300,
1980.
27.
Rumbaut, R. E.,
N. R. Harris,
A. J. Sial,
V. H. Huxley,
and
D. N. Granger.
Leakage responses to L-NAME differ with the fluorescent dye used to label albumin.
Am. J. Physiol.
276 (Heart Circ. Physiol. 45):
H333-H339,
1999
28.
Svensjo, E.,
and
W. L. Joyner.
The effects of intermittent and continuous stimulation of microvessels in the cheek pouch of hamsters with histamine and bradykinin on the development of venular leaky sites.
Microcirc. Endothelium Lymphatics
1:
381-396,
1984[Medline].
29.
Thurston, G.,
A. L. Baldwin,
and
L. M. Wilson.
Changes in endothelial cytoskeleton at leakage sites in the rat mesenteric microvasculature.
Am. J. Physiol.
266 (Heart Circ. Physiol. 35):
H316-H329,
1994.
30.
Wu, N.,
and
A. L. Baldwin.
Transient venular permeability increase and endothelial gap formation induced by histamine.
Am. J. Physiol.
262 (Heart Circ. Physiol. 31):
H1238-H1247,
1992
This article has been cited by other articles:
![]() |
R. O. Dull, B. J. DeWitt, R. Dinavahi, L. Schwartz, C. Hubert, N. Pace, and C. Fronticelli Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction J Appl Physiol, November 1, 2004; 97(5): 1930 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Ginsburg and A. L. Baldwin Disodium cromoglycate stabilizes mast cell degranulation while reducing the number of hemoglobin-induced microvascular leaks in rat mesentery Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1750 - H1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Baldwin, E. B. Wiley, and A. I. Alayash Differential effects of sodium selenite in reducing tissue damage caused by three hemoglobin-based oxygen carriers J Appl Physiol, March 1, 2004; 96(3): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Baldwin, E. B. Wiley, A. G. Summers, and A. I. Alayash Sodium selenite reduces hemoglobin-induced venular leakage in the rat mesentery Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H81 - H91. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Resta, B. R. Walker, M. R. Eichinger, and M. P. Doyle Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity J Appl Physiol, October 1, 2002; 93(4): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Baldwin, E. B. Wiley, and A. I. Alayash Comparison of effects of two hemoglobin-based O2 carriers on intestinal integrity and microvascular leakage Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1292 - H1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. D. T. G. Wagener, A. Eggert, O. C. Boerman, W. J. G. Oyen, A. Verhofstad, N. G. Abraham, G. Adema, Y. van Kooyk, T. de Witte, and C. G. Figdor Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase Blood, September 15, 2001; 98(6): 1802 - 1811. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |